Cargando…

Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study

The mechanisms underlying pulmonary arterial hypertension (PAH) are multifactorial. The efficacy of pulmonary artery denervation (PADN) for idiopathic PAH treatment has been evaluated. This study aimed to analyze the hemodynamic, functional, and clinical responses to PADN in patients with PAH of dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shao-Liang, Zhang, Hang, Xie, Du-Jiang, Zhang, Juan, Zhou, Ling, Rothman, Alexander M.K., Stone, Gregg W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Spotlight Topic: Pulmonary Hypertension
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648183/ https://www.ncbi.nlm.nih.gov/pubmed/26553699 http://dx.doi.org/10.1161/CIRCINTERVENTIONS.115.002837

Ejemplares similares

Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension
por: Rothman, Alexander M.K., et al.
Publicado: (2015)

The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension
por: Wronski, Samantha L., et al.
Publicado: (2019)

Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling
por: Taran, Irina N., et al.
Publicado: (2018)

Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension
por: Chen, Shao-Liang, et al.
Publicado: (2016)

Pulmonary artery denervation improves hemodynamics and cardiac function in pulmonary hypertension secondary to heart failure
por: Zhang, Hang, et al.
Publicado: (2018)

Pulmonary Hypertension in Heart Failure Patients
por: Rao, Sriram D, et al.
Publicado: (2020)

Clinical and hemodynamic profiles of elderly patients with pulmonary arterial hypertension: a single center, prospective study
por: Ozpelit, Ebru, et al.
Publicado: (2017)

How to select the appropriate candidate of pulmonary arterial hypertension: specific therapy in elderly patients with pulmonary hypertension
por: Yaylali, Yalin Tolga
Publicado: (2017)

The progress of pulmonary artery denervation
por: Xie, Yonghui, et al.
Publicado: (2022)

Which prognostic factors should be used in pulmonary arterial hypertension in elderly patients?
por: Akdeniz, Bahri, et al.
Publicado: (2017)

Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension
por: Zuo, Wanyun, et al.
Publicado: (2022)

Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database
por: Heresi, Gustavo A., et al.
Publicado: (2022)

Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
por: Sobiecka, Małgorzata, et al.
Publicado: (2020)

Current status of pulmonary artery denervation
por: Davies, Mark G., et al.
Publicado: (2022)

Transcatheter radiofrequency pulmonary artery denervation in swine: the evaluation of lesion degree, hemodynamics and pulmonary hypertension inducibility
por: Goncharova, Natalia S., et al.
Publicado: (2021)

Correction of tricuspid regurgitation and denervation of pulmonary trunk and pulmonary arteries
por: Yegorovich, Babokin Vadim, et al.
Publicado: (2021)

Pulmonary and Systemic Hemodynamics following Multielectrode Radiofrequency Catheter Renal Denervation in Acutely Induced Pulmonary Arterial Hypertension in Swine
por: Vakhrushev, Aleksandr D., et al.
Publicado: (2021)

Epidemiology of pulmonary hypertension in the elderly
por: Örem, Cihan
Publicado: (2017)

Giant pulmonary artery aneurysm in a patient with schistosomiasis-associated pulmonary arterial hypertension
por: Gavilanes, Francisca, et al.
Publicado: (2018)

Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension
por: Pi, Hongyang, et al.
Publicado: (2022)

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
por: Heukels, Peter, et al.
Publicado: (2021)

Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system
por: Liu, Chen, et al.
Publicado: (2016)

Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension
por: Suzuki, Sho, et al.
Publicado: (2022)

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
por: Goh, Ze Ming, et al.
Publicado: (2022)

The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension
por: van der Bruggen, Cathelijne Emma, et al.
Publicado: (2021)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

COVID-19 AS A PRIMARY CAUSE OF PULMONARY ARTERIAL HYPERTENSION
por: RAVAL, ABHIJIT, et al.
Publicado: (2021)

Familial history of hypertension as a predictor of increased arterial stiffness in normotensive offspring
por: Youssef, Ghada, et al.
Publicado: (2017)

Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2019)

Takayasu’s arteritis with pulmonary artery involvement
por: da Silva, Marina de Moraes Carvalho, et al.
Publicado: (2022)

Extended Renal Artery Denervation Is Associated with Artery Wall Lesions and Acute Systemic and Pulmonary Hemodynamic Changes: A Sham-Controlled Experimental Study
por: Vakhrushev, Aleksandr D., et al.
Publicado: (2020)

Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging
por: Rahaghi, Farbod N., et al.
Publicado: (2021)

Right heart function during simulated altitude in patients with pulmonary arterial hypertension
por: Seccombe, Leigh M, et al.
Publicado: (2017)

Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension
por: Chouvarine, Philippe, et al.
Publicado: (2020)

The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
por: Haddad, Francois, et al.
Publicado: (2022)

Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
por: Wu, Sheryl, et al.
Publicado: (2022)

Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
por: Vizza, Carmine Dario, et al.
Publicado: (2021)

Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension
por: Morrell, Nicholas W., et al.
Publicado: (2013)

The pulmonary hypertension academic research consortium
por: Rich, Stuart
Publicado: (2013)

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f8botv58epgglh9mqdpvo0kg4t